PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 29, 2026Journal of Applied Clinical Medical Physics0 citationsOpen Access

Interpretable LightGBM Model Predicts Radioiodine Therapy Response in Thyroid Carcinoma

Interpretable LightGBM model with SHAP analysis predicts non‐excellent response to initial radioiodine therapy in differentiated thyroid carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

ZLZhaoxia LuoYLYangyang LeiQZQing Zhang

Discussion

Loading...

Member takes

Overview

This analysis predicts therapeutic efficacy in differentiated thyroid carcinoma, implying potential for personalized treatment.

Key Points

  • The study aims to develop an interpretable model for predicting responses to radioiodine therapy in differentiated thyroid carcinoma patients.
  • Developed a LightGBM framework for prediction.
  • Utilized SHAP analysis to interpret risk factors.
  • Focused on primary radioiodine therapeutic efficacy.
  • The model accurately predicts non-excellent responses to therapy.
  • SHAP analysis identified key clinical risk factor contributions.
  • Future enhancements require integrating multi-center data and molecular biomarkers.

Cite This Study

Luo et al. (2026) studied this question.

synapsesocial.com/papers/69c8c2b8de0f0f753b39d20chttps://doi.org/10.1002/acm2.70555
View Full Paper
Ask AI
Bookmark
Share